BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17822319)

  • 1. Dendritic cell counts and their subsets during treatment of multiple myeloma.
    Kovarova L; Buchler T; Pour L; Zahradova L; Ocadlikova D; Svobodnik A; Penka M; Vorlicek J; Hajek R
    Neoplasma; 2007; 54(4):297-303. PubMed ID: 17822319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
    Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
    Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.
    Arpinati M; Chirumbolo G; Urbini B; Bonifazi F; Bandini G; Saunthararajah Y; Zagnoli A; Stanzani M; Falcioni S; Perrone G; Tura S; Baccarani M; Rondelli D
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):106-15. PubMed ID: 14750076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of G-CSF mobilisation on dendritic cell subsets in normal allogeneic donors and patients undergoing autologous transplantation.
    Hock BD; Haring LF; Ebbett AM; Patton WN; McKenzie JL
    Bone Marrow Transplant; 2002 Dec; 30(11):733-40. PubMed ID: 12439695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell recovery after autologous stem cell transplantation.
    Damiani D; Stocchi R; Masolini P; Michelutti A; Sperotto A; Geromin A; Skert C; Cerno M; Michieli M; Baccarani M; Fanin R
    Bone Marrow Transplant; 2002 Sep; 30(5):261-6. PubMed ID: 12209346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin's lymphoma and multiple myeloma.
    Vela-Ojeda J; García-Ruiz Esparza MA; Reyes-Maldonado E; Jiménez-Zamudio L; García-Latorre E; Moreno-Lafont M; Estrada-García I; Mayani H; Montiel-Cervantes L; Tripp-Villanueva F; Ayala-Sánchez M; García-León LD; Borbolla-Escoboza JR
    Ann Hematol; 2006 May; 85(5):308-14. PubMed ID: 16525786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute values of dendritic cell subsets in bone marrow, cord blood, and peripheral blood enumerated by a novel method.
    Szabolcs P; Park KD; Reese M; Marti L; Broadwater G; Kurtzberg J
    Stem Cells; 2003; 21(3):296-303. PubMed ID: 12743324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34+-derived CD11c+ + + BDCA-1+ + CD123+ + DC: expansion of a phenotypically undescribed myeloid DC1 population for use in adoptive immunotherapy.
    Ward KA; Stewart LA; Schwarer AP
    Cytotherapy; 2006; 8(2):130-40. PubMed ID: 16698686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone.
    Bolwell B; Sobecks R; Pohlman B; Andresen S; Theil K; Serafino S; Rybicki L; Kalaycio M
    Bone Marrow Transplant; 2003 Jan; 31(2):95-8. PubMed ID: 12621489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD.
    Rajasekar R; Mathews V; Lakshmi KM; Sellathamby S; George B; Viswabandya A; Daniel D; Chandy M; Srivastava A
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):344-50. PubMed ID: 18275901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the dendritic cell subsets in peripheral blood and its relationship with the expressions of T-bet and GATA-3 in lymphocytes in severe aplastic anemia].
    Wang J; Shao ZH; Fu R; Ruan EB; Qu W; Liang Y; Liu H; Wu YH; Song J; Wang HQ; Xing LM; Guan J; Li LJ; Liu H; Dong SW; You L; Zou P
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):733-6. PubMed ID: 19176008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics.
    Porta MD; Rigolin GM; Alessandrino EP; Maiocchi M; Malcovati L; Vanelli L; Baratè C; Rumi E; Ciccone M; Cuneo A; Lazzarino M; Castoldi G
    Eur J Haematol; 2004 Jan; 72(1):18-25. PubMed ID: 14962258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-CSF increases the number of peripheral blood dendritic cells CD16+ and modifies the expression of the costimulatory molecule CD86+.
    Talarn C; Urbano-Ispizua A; Martino R; Batlle M; Fernández-Avilés F; Herrera C; Pérez-Simón JA; Gaya A; Aymerich M; Pétriz J; Marín P; Sierra J; Montserrat E
    Bone Marrow Transplant; 2006 May; 37(9):873-9. PubMed ID: 16547488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
    de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J
    Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific T-cell immunity in multiple myeloma patients is restored following high-dose therapy: implications for timing of vaccination.
    Svane IM; Nikolajsen K; Johnsen HE
    Scand J Immunol; 2007 Oct; 66(4):465-75. PubMed ID: 17850592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells.
    Teleshova N; Jones J; Kenney J; Purcell J; Bohm R; Gettie A; Pope M
    J Leukoc Biol; 2004 Jun; 75(6):1102-10. PubMed ID: 15075365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the polish population.
    Narbutt J; Lesiak A; Zak-Prelich M; Woźniacka A; Sysa-Jedrzejowska A; Tybura M; Robak T; Smolewski P
    Cell Mol Biol Lett; 2004; 9(3):497-509. PubMed ID: 15332126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets.
    Beckebaum S; Zhang X; Chen X; Yu Z; Frilling A; Dworacki G; Grosse-Wilde H; Broelsch CE; Gerken G; Cicinnati VR
    Clin Cancer Res; 2004 Nov; 10(21):7260-9. PubMed ID: 15534100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.